Robert J. Beckman
Robert J. Beckman is Managing Partner and co-founder of The Channel Group, a strategic advisory and management firm specializing in healthcare transactions. He was previously a co-founder and immediate past CEO of Intergen Company, which he founded through a management buyout of Armour Pharmaceutical Co.’s biochemical business from Rorer Group Inc.
Under Beckman’s guidance, Intergen became a global leader focused on providing technology and biologicals to the pharmaceutical, biotechnology, and clinical diagnostic industries. Beckman led the company through its profitable history during which time Intergen acquired five companies, created business units in Canada, Europe, and Japan, established significant manufacturing capacities, and developed an extensive portfolio of technology that it sold and licensed for use in cancer research, pharmaceutical discovery, and genomics.
Stephen H. Blose, V.M.D., Ph.D.
Stephen H. Blose, V.M.D, Ph.D., Managing Partner of The Channel Group, has more than 30 years of executive management experience in building successful life sciences, diagnostics, and medical device businesses. He was previously the founder of the Mill Valley Summit Group, LLC, that helped early-stage companies raise capital through venture financings and, licensing and asset transactions. Previously, Dr. Blose served as General Manager of Bio-Rad Laboratories Inc.’s Imaging Products Division, a position he assumed upon Bio-Rad’s acquisition of Protein Databases, Inc., where he served as CEO. During his tenure at Protein Databases, the company developed significant relationships with Millipore Corporation (now part of Merck KGaA, Darmstadt), Pharmacia LKB Biotechnology (now GE Healthcare), and Toyobo Co., Ltd. Prior to that he was a Senior Scientist in the laboratory of Nobel Laureate James D. Watson at Cold Spring Harbor Laboratory, conducting research on cancer proteomics. He is regarded as one of the founders of the proteomics industry.
Dr. Blose is the former Chairman of the Board of Directors and Audit Committee member of BioMicro Systems, Inc. (sold to Hoffman La-Roche Diagnostics), former Board Director and Board Secretary of Sentrx Animal Care, Inc., Board Secretary and Chief Business Officer of Lumiphore, Inc., and a Founding Director of the New York Biotechnology Association. While at the University of Pennsylvania, he earned a Ph.D. in experimental pathology and cell biochemistry and a V.M.D. in veterinary medicine. Dr. Blose is based in the San Francisco Bay area.
Prof. Heiko von der Leyen
Prof. Heiko von der Leyen, MD, PhD is the co-founder and managing director of Hannover Clinical Trial Center GmbH (HCTC). HCTC was founded in 2005 and is an academic Contract Research Organization (CRO) dedicated to provide clinical trial management services and early product development support. HCTC combines the clinical expertise and academic leadership of a premier German teaching hospital with the full-service operational capabilities of a Contract Research Organization (including biostatistics, clinical monitoring, data management).
Prof. von der Leyen was trained in Pharmacology, Internal Medicine, and Cardiology at University of Hamburg, Hannover Medical School and Stanford University, CA, USA. He was Junior faculty member at the Division of Cardiovascular Medicine of Stanford University with research focus in cardiovascular gene therapy from 1995 to 1996. From 1998 to 2005 Prof. von der Leyen had several top management positions in the biotechnology industry with focus on the clinical development of advanced therapy medicinal products (tissue engineering, gene therapy, DNA medicine).
Haim Ramon is a former Member of the Knesset and served as Israel’s Vice Prime Minister from 2007-2009. He was first elected to the Knesset in 1983 and since then served as a member of several Knesset Committees, such as Labor Coordinator in the Finance Committee, Interior Minister, Minister of Health and in an interim period as Chairman of the Histadrut (the general trade union). He was the engineer and the engine of what was called the “Health Revolution” – by legislating the National Health Insurance Act. From 1996 onwards Ramon served as a member, and later on as Chairman, of the Knesset Foreign Affairs and Defense Committee. In 2005 he was Minister without portfolio and then was appointed as Minister of Justice and Vice Prime Minister in 2007. In 2009 he was again elected as Member of the Knesset.
Ramon is a law graduate of Tel Aviv University and works as a lawyer. Besides his position as Director in Adgar Investments & Development Ltd, the real estate division of the Zur Shamir group, which is a leading Israeli holding company in the field of finance, insurance and real estate, he is active in real estate and hotel projects in Germany. Ramon serves as Director for the public insurance company Direct Insurance Financial Investments Ltd., and its subsidiary Direct Financing, a consumer credit company.
In the past, Haim Ramon was involved in many business activities, such as Advisor to the Head of Keter Group Ltd., one of the largest plastic manufacturers and marketers in the world, Director for a public company called “Mif’alim Petrochimiyeem” Ltd. – Israel Petrochemicals, and owner of the Hapoel Tel Aviv Football Club.